1. NCCU Academic Hub
  2. 學術產出
  3. College of Commerce
  4. Theses
  5. Item

學術產出-Theses

Article View/Open

Publication Export

Google ScholarTM

政大圖書館

Citation Infomation

  • No doi shows Citation Infomation
題名 歐洲主要市場奈米科技產品之商業化
Nano technology product commercialization in key european markets
作者 何淑珊
Sampath, Shubha
貢獻者 何小台
Ho, Chester
何淑珊
Sampath, Shubha
關鍵詞 奈米科技
日期 2008
上傳時間 18-Sep-2009 20:28:19 (UTC+8)
摘要 歐洲主要市場奈米科技產品之商業化
Objectives of the research: To identify commercial possibilities and develop an entry strategy for Nano technology product in the healthcare segment for key Western European markets. To investigate the Benelux and German customer landscape by collecting data via hospital and field expert interviews. To compile the research findings to formulate the Europe market entry strategy and provide future recommendations.

Executive Summary
This paper sets out to research the European market entry possibilities of ‘Nano technology Product’, an antimicrobial surface treatment that uses nano-scale technology to kill bacteria and viruses upon contact.

Through face-to-face interviews with infectious disease professionals in the hospital environment, a research was conducted to understand, what needs end-users have and which procedures and products are currently employed. Furthermore, the research aimed to reveal how aware potential customers are about nanotechnology in general and ‘Nano technology Product’ in specific, what institutions govern the landscape and how end users’ budgets are set.

Based on an analysis of the institutional landscape in the Netherlands, Germany and Belgium, a recommended market entry strategy is created for the ‘Nano technology Product’.
參考文獻 Articles & Reports
 Karchmer, Durbiny, Simontony, & Farry (2002), Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus, Journal of Hospital Infection
 IGZ (Inspectie voor de Gezonsheidszorg, or Healthcare Inpection) (2008), Rapport van het onderzoek naar het peroperatief proces in de IJsselmeerziekenhuizen te Lelystad en Emmeloord op 5 en 12 september 2008, available on www.igz.nl
 Kim, Oh & Simor (2001), The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals, Infection Control & Hospital Epidemiology
 Kunori, T. (2001), Cost-effectiveness of different MRSA screening methods, Journal of Hospital Infection
 Wertheim, H.F.L. et al. (2004), Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic, Journal of Hospital Infection
 Stone, K. (2008), The Rise of MRSA in Pigs and the Health Risk to Humans, http://www.naturalnews.com/023725.html
Websites
 http://www.cbo.nl/english/article20030512115620/articleCBOextra_view, Accessed November, 11 2008
 http://www.allesovermrsa.nl/, Accessed on December, 10 2008
 www.cdc.com, Accessed on December, 12 2008
 https://www.cia.gov/library/publications/the-world-factbook/, Accessed on December, 13 2008
 https://portal.health.fgov.be/portal/page?_pageid=56,4190386&_ dad=portal&_schema=PORTAL&_menu=menu_3_1, Accessed on November, 11 2008
 http://www.iph.fgov.be/Index.asp?Lang=EN&Proc=MISSION, Accessed on November, 31 2008
 http://www.rivm.nl/en/aboutrivm/what/, Accessed on November, 11 2008
 http://www.vah-online.de/cmsmadesimple/index.php?page=vah-2, Accessed on November, 11 2008
 http://www.infectieziekten.org/, Accessed on December, 11 2008
 http://www.wip.nl/UK/, Accessed on December, 11 2008
 http://www.vah-online.de/cmsmadesimple/uploads/PDF/FlyerVAH_116.pdf, Accessed on December, 5 2008
 http://www.ilpi.com/msdS/ref/concentration.html, Accessed on December, 12 2008
 http://www.rki.de/cln_100/nn_201414/DE/Content/Infekt/Krankenhaushygiene/Kommission/Downloads/Ausbr__Rili,templateId=raw,property=publicationFile.pdf/Ausbr_Rili.pdf, Accessed on December, 12 2008
Articles & reports
• Amnesty International (2008), Voorwoord jaarboek 2008: Geschonden beloften. http://www.amnesty.nl/bibliotheek_vervolg/jaarboek2008_voorwoord
• Cernic, J.L. (2008), Corporate Responsibility for Human Rights: A Critical Analysis of the OECD Guidelines for Multinational Enterprises, Hanse Law Review.
• Books
• Sachs, Jeffrey D. (2008) Common Wealth: economics for a crowded planet, Londen: Penguin Books Ltd.
描述 碩士
國立政治大學
國際經營管理碩士班(IMBA)
95933056
97
資料來源 http://thesis.lib.nccu.edu.tw/record/#G0095933056
資料類型 thesis
dc.contributor.advisor 何小台zh_TW
dc.contributor.advisor Ho, Chesteren_US
dc.contributor.author (Authors) 何淑珊zh_TW
dc.contributor.author (Authors) Sampath, Shubhaen_US
dc.creator (作者) 何淑珊zh_TW
dc.creator (作者) Sampath, Shubhaen_US
dc.date (日期) 2008en_US
dc.date.accessioned 18-Sep-2009 20:28:19 (UTC+8)-
dc.date.available 18-Sep-2009 20:28:19 (UTC+8)-
dc.date.issued (上傳時間) 18-Sep-2009 20:28:19 (UTC+8)-
dc.identifier (Other Identifiers) G0095933056en_US
dc.identifier.uri (URI) https://nccur.lib.nccu.edu.tw/handle/140.119/37014-
dc.description (描述) 碩士zh_TW
dc.description (描述) 國立政治大學zh_TW
dc.description (描述) 國際經營管理碩士班(IMBA)zh_TW
dc.description (描述) 95933056zh_TW
dc.description (描述) 97zh_TW
dc.description.abstract (摘要) 歐洲主要市場奈米科技產品之商業化zh_TW
dc.description.abstract (摘要) Objectives of the research: To identify commercial possibilities and develop an entry strategy for Nano technology product in the healthcare segment for key Western European markets. To investigate the Benelux and German customer landscape by collecting data via hospital and field expert interviews. To compile the research findings to formulate the Europe market entry strategy and provide future recommendations.

Executive Summary
This paper sets out to research the European market entry possibilities of ‘Nano technology Product’, an antimicrobial surface treatment that uses nano-scale technology to kill bacteria and viruses upon contact.

Through face-to-face interviews with infectious disease professionals in the hospital environment, a research was conducted to understand, what needs end-users have and which procedures and products are currently employed. Furthermore, the research aimed to reveal how aware potential customers are about nanotechnology in general and ‘Nano technology Product’ in specific, what institutions govern the landscape and how end users’ budgets are set.

Based on an analysis of the institutional landscape in the Netherlands, Germany and Belgium, a recommended market entry strategy is created for the ‘Nano technology Product’.		en_US
dc.description.tableofcontents Over View 2
Executive Summary 2
Chapter 1: Introduction 7
1.1 The Company 7
1.2 ‘Nano technology Product’ 7
Chapter 2: Key Issues 8
2.1 Identified Issue 8
2.2 Overall Objective 8
2.3 Research Question 8
Chapter 2: Key Issues 9
3.1 Conceptual Framework 9
3.2 Procedure 9
3.2.1 Background Research 9
3.2.2 Hospital and Field Expert Selection 9
3.2.3 Interviews 10
Chapter 4: Main Issues 11
4.1 Infectious Diseases 11
4.1.1 Overview 11
4.1.2 The Netherlands 11
4.1.3 Germany 12
4.1.4 Belgium 12
4.2 Transmission Mechanisms 13
4.2.1 Overview 13
4.2.2 Hand Hygiene & Compliance 13
4.2.3 Surfaces 13
4.2.4 Linens 13
4.2.5 Air Travel 13
Chapter 5: Product Fit 16
5.1 Product Perception 16
5.1.1 Overview 16
5.1.2 Awareness 16
5.1.3 Concerns 17
5.1.4 Interest 17
5.2 Applications 17
5.2.1 Overview 17
5.2.2 Application Areas 18
5.2.3 Specific Applications 18
Chapter 6: Procedural & Competitive Landscape 20
6.1 Hospital Hygiene Products & Procedures 20
6.1.1 Overview 20
6.1.2 Hand and Surface Disinfection 21
6.1.3 Disinfection of Linens 22
6.1.4 Air Filtration 22
6.1.5 Water Filtration 23
6.2 Hospital Hygiene Practices 24
6.3 Competing Technologies & New Product Research 25
6.3.1 Overview 25
6.3.2 The Netherlands 25
6.3.3 Germany 25
6.3.4 Belgium 25
Chapter 7: Fiscal & Institutional Landscape 27
7.1 Relevant Institutions 27
7.1.1 Overview 27
Table 7.1: Institutional landscape overview 27
7.1.2 The Netherlands 28
7.1.3 Germany 30
7.1.4 Belgium 32
7.1.5 Europe 34
7.2 Key Decision Makers 34
7.2.1 Overview 34
7.2.2 Key Decision Makers 35
7.3 Outbreak Procedures 35
7.3.1 Overview 35
7.3.2 The Netherlands 36
7.3.3 Germany 37
7.3.4 Belgium 38
7.4 Budget 39
7.4.1 Overview 39
7.4.2 The Netherlands 39
7.4.3 Germany 39
7.4.4 Belgium 40
Chapter 8: Conclusions 40
8.1 Main Issues 40
8.2 Product Fit 42
8.3 Procedural & Competitive Landscape 43
8.4 Institutional Landscape 44
Chapter 9: Recommendations 49
9.1 Market Entry Point 49
9.1.1 Germany 49
9.1.2 Belgium 50
9.1.3 The Netherlands 50
9.2 Market Entry Strategy 51
9.2.1 Germany 51
9.2.2 Belgium 53
9.2*Ireland as the Port of Entry
9.3 Further Research 54
9.3.1 Methodology Insights 54
9.3.2 Further Research Opportunities 54
Chapter 10: Reflections 55
10.1 Learnings & Limitations 55
10.1.1 Anticipated Challenges 55
10.1.2 Actual Challenges 55
10.2 Value Created 56
Bibliography 57
Appendices 59
Appendix A: Sample Interview Questionnaire 59
Appendix B: Sample Online Survey 62
Appendix C: Interview Contact List 66
Appendix D:Main Issues 67
Appendix E: Ten-step outbreak scheme by Robert Koch Institute 68
Appendix F: Interview Transcripts 70
Appendix G: Berlin ESCAIDE Conference Notes 120
Appendix H: Online Survey Results 124		zh_TW
dc.format.extent 102357 bytes-
dc.format.extent 66957 bytes-
dc.format.extent 85144 bytes-
dc.format.extent 90309 bytes-
dc.format.extent 67460 bytes-
dc.format.extent 86567 bytes-
dc.format.extent 163400 bytes-
dc.format.extent 78059 bytes-
dc.format.extent 76548 bytes-
dc.format.extent 169529 bytes-
dc.format.extent 237457 bytes-
dc.format.extent 94298 bytes-
dc.format.extent 114335 bytes-
dc.format.extent 89514 bytes-
dc.format.extent 104482 bytes-
dc.format.extent 719787 bytes-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.format.mimetype application/pdf-
dc.language.iso en_US-
dc.source.uri (資料來源) http://thesis.lib.nccu.edu.tw/record/#G0095933056en_US
dc.subject (關鍵詞) 奈米科技zh_TW
dc.title (題名) 歐洲主要市場奈米科技產品之商業化zh_TW
dc.title (題名) Nano technology product commercialization in key european marketsen_US
dc.type (資料類型) thesisen
dc.relation.reference (參考文獻) Articles & Reportszh_TW
dc.relation.reference (參考文獻)  Karchmer, Durbiny, Simontony, & Farry (2002), Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus, Journal of Hospital Infectionzh_TW
dc.relation.reference (參考文獻)  IGZ (Inspectie voor de Gezonsheidszorg, or Healthcare Inpection) (2008), Rapport van het onderzoek naar het peroperatief proces in de IJsselmeerziekenhuizen te Lelystad en Emmeloord op 5 en 12 september 2008, available on www.igz.nlzh_TW
dc.relation.reference (參考文獻)  Kim, Oh & Simor (2001), The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals, Infection Control & Hospital Epidemiologyzh_TW
dc.relation.reference (參考文獻)  Kunori, T. (2001), Cost-effectiveness of different MRSA screening methods, Journal of Hospital Infectionzh_TW
dc.relation.reference (參考文獻)  Wertheim, H.F.L. et al. (2004), Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic, Journal of Hospital Infectionzh_TW
dc.relation.reference (參考文獻)  Stone, K. (2008), The Rise of MRSA in Pigs and the Health Risk to Humans, http://www.naturalnews.com/023725.htmlzh_TW
dc.relation.reference (參考文獻) Websiteszh_TW
dc.relation.reference (參考文獻)  http://www.cbo.nl/english/article20030512115620/articleCBOextra_view, Accessed November, 11 2008zh_TW
dc.relation.reference (參考文獻)  http://www.allesovermrsa.nl/, Accessed on December, 10 2008zh_TW
dc.relation.reference (參考文獻)  www.cdc.com, Accessed on December, 12 2008zh_TW
dc.relation.reference (參考文獻)  https://www.cia.gov/library/publications/the-world-factbook/, Accessed on December, 13 2008zh_TW
dc.relation.reference (參考文獻)  https://portal.health.fgov.be/portal/page?_pageid=56,4190386&_ dad=portal&_schema=PORTAL&_menu=menu_3_1, Accessed on November, 11 2008zh_TW
dc.relation.reference (參考文獻)  http://www.iph.fgov.be/Index.asp?Lang=EN&Proc=MISSION, Accessed on November, 31 2008zh_TW
dc.relation.reference (參考文獻)  http://www.rivm.nl/en/aboutrivm/what/, Accessed on November, 11 2008zh_TW
dc.relation.reference (參考文獻)  http://www.vah-online.de/cmsmadesimple/index.php?page=vah-2, Accessed on November, 11 2008zh_TW
dc.relation.reference (參考文獻)  http://www.infectieziekten.org/, Accessed on December, 11 2008zh_TW
dc.relation.reference (參考文獻)  http://www.wip.nl/UK/, Accessed on December, 11 2008zh_TW
dc.relation.reference (參考文獻)  http://www.vah-online.de/cmsmadesimple/uploads/PDF/FlyerVAH_116.pdf, Accessed on December, 5 2008zh_TW
dc.relation.reference (參考文獻)  http://www.ilpi.com/msdS/ref/concentration.html, Accessed on December, 12 2008zh_TW
dc.relation.reference (參考文獻)  http://www.rki.de/cln_100/nn_201414/DE/Content/Infekt/Krankenhaushygiene/Kommission/Downloads/Ausbr__Rili,templateId=raw,property=publicationFile.pdf/Ausbr_Rili.pdf, Accessed on December, 12 2008zh_TW
dc.relation.reference (參考文獻) Articles & reportszh_TW
dc.relation.reference (參考文獻) • Amnesty International (2008), Voorwoord jaarboek 2008: Geschonden beloften. http://www.amnesty.nl/bibliotheek_vervolg/jaarboek2008_voorwoordzh_TW
dc.relation.reference (參考文獻) • Cernic, J.L. (2008), Corporate Responsibility for Human Rights: A Critical Analysis of the OECD Guidelines for Multinational Enterprises, Hanse Law Review.zh_TW
dc.relation.reference (參考文獻) • Bookszh_TW
dc.relation.reference (參考文獻) • Sachs, Jeffrey D. (2008) Common Wealth: economics for a crowded planet, Londen: Penguin Books Ltd.zh_TW